CJ Bioscience Logo

CJ Bioscience

Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.

311690 | KO

Overview

Corporate Details

ISIN(s):
KR7311690002
LEI:
Country:
South Korea
Address:
서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구

Description

CJ Bioscience is a company focused on developing microbiome-based therapeutics to address unmet medical needs. It utilizes a proprietary AI-powered drug discovery platform, Ez-Mx®, to identify and advance novel live biotherapeutic products (LBPs). The company's primary focus is on creating treatments for complex diseases, with a pipeline targeting oncology and inflammatory bowel disease (IBD). Key candidates include CJRB-101, its lead oncology asset, and CJRB-201, a promising oral therapeutic for IBD that has demonstrated significant anti-inflammatory efficacy in preclinical models. In addition to its drug development programs, CJ Bioscience provides next-generation sequencing (NGS) and bioinformatics solutions to the global research community through its EzBioCloud platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 5.9 KB
2025-08-14 00:00
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.0 KB
2025-08-14 00:00
임시주주총회결과
Korean 7.3 KB
2025-08-14 00:00
대표이사변경
Korean 10.7 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-30 00:00
주주총회소집공고
Korean 46.5 KB
2025-07-08 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-07-08 00:00
주주총회소집결의
Korean 9.0 KB
2025-06-02 00:00
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 81.9 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-03-26 00:00
정기주주총회결과
Korean 17.4 KB
2025-03-17 00:00
감사보고서제출
Korean 26.0 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 376.8 KB
2025-03-05 00:00
주주총회소집공고
Korean 166.0 KB
2025-03-04 00:00
주주총회소집결의
Korean 7.4 KB

Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CJ Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CJ Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.